Genetic clues could personalize arthritis drug treatment
NCT ID NCT07388407
First seen Feb 05, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study looks at how genetic differences in Pakistani people with rheumatoid arthritis affect their response to the drug leflunomide. Researchers will take blood samples and track disease activity and side effects over six months. The goal is to create a genetic guide to help doctors choose the best treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fauji Foundation Hospital, Rawalpindi
RECRUITINGRawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shifa International Hospital
COMPLETEDIslamabad, Punjab Province, 44000, Pakistan
Conditions
Explore the condition pages connected to this study.